Liquidia Corporation (LQDA) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Liquidia Corporation third quarter 2025 financial results and corporate update conference call. My name is Carmen, and I will be your operator today. All participants are current in analysis-only mode. Following the presentation, we will conduct a question and answer session. Instructions for joining the queue will be provided at that time. Please note that today's call is being recorded. I now turn the call over to Jason Adair, Chief Business Officer. Thank you, Carmen, and good morning, everyone. It's my pleasure to welcome you to Liquidia's third quarter 2025 financial results and corporate update conference call. Joining me today are Dr. Roger Jeff, Chief Executive Officer, Michael Cassetta, Chief Operating Officer and Chief Financial Officer, Dr. Rajiv Sagar, Chief Medical Officer, Scott Mummo, Chief Commercial Officer, and Rusty Schundler, General Counsel. Before we begin, please note that today's discussion will include forward-looking statements, including statements regarding future results, product performance, and ongoing clinical or commercial activity. These statements are subject to risks and uncertainties that may cause actual results to differ materially. For further information, please refer to our filings with the SEC available on our website. Please note that our earnings release, our commentary, and our slide deck accompanying this call include non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures can be found in our earnings release and the slide deck accompanying this call. With that, I'll turn the call over to Roger Jeffs, our Chief Executive Officer. Roger? Thanks, Jason, and good morning, everyone. This morning, I want to begin by expressing just...